Published in Am J Hematol on January 01, 1980
The efficacy of PlA1-negative platelet transfusion therapy in posttransfusion purpura. West J Med (1988) 0.75
Post-transfusion purpura: a rare and life-threatening aetiology of thrombocytopenia. BMJ Case Rep (2013) 0.75
Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest (1966) 2.43
IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY". J Clin Invest (1961) 2.28
Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature (1969) 2.16
The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest (1989) 1.94
T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med (1983) 1.91
A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies. J Clin Invest (1969) 1.91
4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J Immunol (2001) 1.90
Use of "compatible" platelet transfusions in treatment of congenital isoimmune thrombocytopenic purpura. N Engl J Med (1969) 1.71
Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest (1988) 1.63
Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes. J Lab Clin Med (1996) 1.58
A study of variables affecting the quality of platelets stored at "room temperature". Transfusion (1976) 1.52
A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia (2005) 1.51
TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion (2003) 1.50
Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg (1999) 1.48
The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med (2007) 1.43
Types of patients in a psychiatric intensive care unit. Aust N Z J Psychiatry (2001) 1.42
Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood (1994) 1.40
A study of criteria for blood donor deferral. Transfusion (1980) 1.39
Heparin-induced thrombocytopenia: understanding improves but questions remain. J Lab Clin Med (1996) 1.39
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest (1994) 1.38
Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. Transfusion (1994) 1.33
Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. Blood (1965) 1.28
Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII). N Engl J Med (1983) 1.27
Sites of platelet destruction in idiopathic thrombocytopenic purpura. Br J Haematol (1969) 1.24
Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose. J Am Geriatr Soc (1999) 1.22
Isolation and immunologic characterization of the human platelet alloantigen, P1A1. Mol Immunol (1979) 1.21
Development of an owner-assessed scale to measure the severity of pruritus in dogs. Vet Dermatol (2007) 1.21
Heparin-induced thrombocytopenia and thrombosis. Am J Hematol (2006) 1.20
Measurement of body fat using leg to leg bioimpedance. Arch Dis Child (2001) 1.18
Increased splenic pooling and the pathogenesis of hypersplenism. Am J Med Sci (1967) 1.18
Post-transfusion purpura: successful treatment by exchange transfusion. N Engl J Med (1972) 1.18
Blood group A and B antigens are strongly expressed on platelets of some individuals. Blood (2000) 1.17
The carboxyl-terminal sequence of the human secretory mucin, MUC6. Analysis Of the primary amino acid sequence. J Biol Chem (1997) 1.17
Detection of drug-dependent antibodies by the 51Cr platelet lysis test: documentation of immune thrombocytopenia induced by diphenylhydantoin, diazepam, and sulfisoxazole. Am J Hematol (1977) 1.16
Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion (1990) 1.14
Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome. J Clin Invest (1978) 1.14
Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario. CMAJ (1999) 1.11
Expression of HLA-B12, HLA-B8, w4, and w5 on platetelets. Transplant Proc (1977) 1.10
Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis. J Lab Clin Med (2001) 1.10
Modifications in the alditol acetate method for analysis of muramic acid and other neutral and amino sugars by capillary gas chromatography-mass spectrometry with selected ion monitoring. J Chromatogr (1985) 1.09
Febrile transfusion reaction: what blood component should be given next? Vox Sang (1982) 1.08
The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD. Mol Endocrinol (1999) 1.08
Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians. Transfusion (1996) 1.07
Studies of platelet concentrates stored at 22 C nad 4 C. Transfusion (1973) 1.07
Development of an automated blood inventory and information system for a regional transfusion service. Transfusion (1970) 1.07
Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest (1985) 1.06
Suppressor of cytokine signalling gene expression is elevated in breast carcinoma. Br J Cancer (2003) 1.05
Deletion of the platelet-specific alloantigen PlA1 from platelets in Glanzmann's thrombasthenia. J Clin Invest (1978) 1.05
Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia. J Clin Invest (1982) 1.05
Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka/Bakb alloantigen system. Blood (1990) 1.05
The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line. J Bone Miner Res (1989) 1.05
On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest (1987) 1.02
Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha. J Biol Chem (2000) 1.01
Platelet migration inhibition: a new method for detection of platelet antibodies. Blood (1975) 1.01
Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract (2006) 1.01
Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood (1991) 1.00
Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity. Blood (1991) 1.00
Further studies of the human platelet receptor for quinine- and quinine-dependent antibodies. J Immunol (1981) 1.00
Specificity of lumbar medial branch and L5 dorsal ramus blocks. A computed tomography study. Spine (Phila Pa 1976) (1997) 0.99
Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/thrombosis. Blood (1999) 0.99
Oxysterols induce differentiation in human keratinocytes and increase Ap-1-dependent involucrin transcription. J Invest Dermatol (2000) 0.98
Clinical significance of platelet-specific antigens and antibodies. Prog Clin Biol Res (1984) 0.98
Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression. Blood (1992) 0.98
Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a "new" maternal antiplatelet antibody. Blood (1985) 0.97
Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle. Nucleic Acids Res (2010) 0.97
Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. J Thromb Haemost (2004) 0.95
Characterization of the humoral immune response in heparin-induced thrombocytopenia. Am J Hematol (1997) 0.95
Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost (2011) 0.94
Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature. Am J Hematol (1994) 0.94
Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies. Br J Haematol (1996) 0.94
The low density lipoprotein receptor-related protein contributes to selective uptake of high density lipoprotein cholesteryl esters by SW872 liposarcoma cells and primary human adipocytes. J Biol Chem (2001) 0.93
Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays. Transfusion (2003) 0.93
Determination of neutrophil antigen gene frequencies in five ethnic groups by polymerase chain reaction with sequence-specific primers. Transfusion (1996) 0.92
Prevalence of human papillomavirus types 16 and 18 in penile carcinoma: a study of 41 cases using PCR. J Clin Pathol (1994) 0.92
Treatment of thrombotic thrombocytopenic purpura by exchange transfusion. Am J Hematol (1977) 0.92
Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C. J Lab Clin Med (1978) 0.92
Changes associated with platelet aging. Thromb Diath Haemorrh (1972) 0.92
Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol (1977) 0.92
Heparin-induced thrombocytopenia and thrombosis. N Engl J Med (1995) 0.92
Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes. Blood (1991) 0.91
Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood (1985) 0.91
Direct quantitation of platelet-associated IgG by electroimmunoassay. Blood (1982) 0.90
Structural features of the quinidine and quinine molecules necessary for binding of drug-induced antibodies to human platelets. J Lab Clin Med (1984) 0.90
Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet (2000) 0.89
Tissue-specific induction of SOCS gene expression by PRL. Endocrinology (2001) 0.89
Concurrence of anaphylaxis and acute heparin-induced thrombocytopenia in a patient with heparin-induced antibodies. J Vasc Surg (1998) 0.89
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther (2001) 0.89
The P1A alloantigen system is a sensitive indicator of the structural integrity of the amino-terminal domain of the human integrin beta 3 subunit. Blood Cells Mol Dis (1995) 0.89
Lipid composition of freshly prepared and stored platelet concentrates. Blood (1980) 0.88
Effects of pH treatments and deglycosylation of rabbit immunoglobulin G on the binding of C1q. J Biol Chem (1980) 0.88
Studies of the fate of platelets in rats and man. Blood (1969) 0.87
An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies. Blood (1998) 0.87
Post-transfusion purpura: immunologic aspects and therapy. N Engl J Med (1974) 0.87
Vitamin D status among patients with fractured neck of femur in Hong Kong. Bone (1990) 0.87
Thrombotic thrombocytopenic purpura: early and late responders. Am J Hematol (1997) 0.86
Cholesterol sulfate stimulates involucrin transcription in keratinocytes by increasing Fra-1, Fra-2, and Jun D. J Lipid Res (2001) 0.86
An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system. J Clin Invest (1992) 0.86
"Gestational" thrombocytopenia: a plea for conservative management. N Engl J Med (1990) 0.85